Laddar...
SAT-453 Diabetic "Ketoalkalosis" Due to SGLT2 Inhibitor in the Setting of Cushing's Disease
Introduction - The combination of sodium glucose cotransporter-2 inhibitor (SGLT-2i) use and glucocorticoid excess can trigger ketone production by reducing insulin secretion/sensitivity and stimulating glucosuria, glucagon production, and lipolysis. In addition, metabolic alkalosis caused by glucoc...
Sparad:
| I publikationen: | J Endocr Soc |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Endocrine Society
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552005/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-453 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|